These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Death due to bioterrorism-related inhalational anthrax: report of 2 patients. Borio L; Frank D; Mani V; Chiriboga C; Pollanen M; Ripple M; Ali S; DiAngelo C; Lee J; Arden J; Titus J; Fowler D; O'Toole T; Masur H; Bartlett J; Inglesby T JAMA; 2001 Nov; 286(20):2554-9. PubMed ID: 11722269 [TBL] [Abstract][Full Text] [Related]
4. Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients. Mayer TA; Bersoff-Matcha S; Murphy C; Earls J; Harper S; Pauze D; Nguyen M; Rosenthal J; Cerva D; Druckenbrod G; Hanfling D; Fatteh N; Napoli A; Nayyar A; Berman EL JAMA; 2001 Nov; 286(20):2549-53. PubMed ID: 11722268 [TBL] [Abstract][Full Text] [Related]
5. Isolated case of bioterrorism-related inhalational anthrax, New York City, 2001. Holtz TH; Ackelsberg J; Kool JL; Rosselli R; Marfin A; Matte T; Beatrice ST; Heller MB; Hewett D; Moskin LC; Bunning ML; Layton M Emerg Infect Dis; 2003 Jun; 9(6):689-96. PubMed ID: 12781008 [TBL] [Abstract][Full Text] [Related]
6. Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(47):1049-51. PubMed ID: 11808925 [TBL] [Abstract][Full Text] [Related]
7. Index case of fatal inhalational anthrax due to bioterrorism in the United States. Bush LM; Abrams BH; Beall A; Johnson CC N Engl J Med; 2001 Nov; 345(22):1607-10. PubMed ID: 11704685 [No Abstract] [Full Text] [Related]
8. Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infant. Freedman A; Afonja O; Chang MW; Mostashari F; Blaser M; Perez-Perez G; Lazarus H; Schacht R; Guttenberg J; Traister M; Borkowsky W JAMA; 2002 Feb; 287(7):869-74. PubMed ID: 11851579 [TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of bioterrorism-related inhalational anthrax. Tepper M; Whitehead J Lancet; 2005 Jan 15-21; 365(9455):214; author reply 215. PubMed ID: 15652600 [No Abstract] [Full Text] [Related]
13. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(41):889-93. PubMed ID: 11686472 [TBL] [Abstract][Full Text] [Related]
16. Clinical predictors of bioterrorism-related inhalational anthrax. Gair R Lancet; 2005 Jan 15-21; 365(9455):214-5; author reply 215. PubMed ID: 15652599 [No Abstract] [Full Text] [Related]
17. From the Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related inhalation anthrax--Connecticut, 2001. JAMA; 2001 Dec; 286(23):2936-7. PubMed ID: 11787482 [No Abstract] [Full Text] [Related]
18. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):941-8. PubMed ID: 11708591 [TBL] [Abstract][Full Text] [Related]
19. Fatal case of inhalational anthrax mimicking intra-abdominal sepsis. Quintiliani R; Quintiliani R Conn Med; 2002 May; 66(5):261-7. PubMed ID: 12071107 [TBL] [Abstract][Full Text] [Related]
20. From the Centers for Disease Control and Prevention. Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. JAMA; 2001 Nov; 286(17):2086-8. PubMed ID: 11757496 [No Abstract] [Full Text] [Related] [Next] [New Search]